Telix Pharmaceuticals Limited Stock Target Price
TLPPF Stock | USD 16.00 0.82 5.40% |
Telix Pharmaceuticals Limited fundamentals help investors to digest information that contributes to Telix Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Telix Pink Sheet. The fundamental analysis module provides a way to measure Telix Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Telix Pharmaceuticals pink sheet.
Telix |
Did you try this?
Run Equity Analysis Now
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
All Next | Launch Module |
Telix Fundamentals
Return On Equity | -1.55 | |||
Return On Asset | -0.41 | |||
Operating Margin | (3.95) % | |||
Current Valuation | 1.39 B | |||
Shares Outstanding | 317.02 M | |||
Shares Owned By Insiders | 27.60 % | |||
Shares Owned By Institutions | 13.59 % | |||
Price To Book | 21.16 X | |||
Price To Sales | 52.21 X | |||
Revenue | 4.9 M | |||
Gross Profit | 5.05 M | |||
EBITDA | (70.07 M) | |||
Net Income | (80.51 M) | |||
Cash And Equivalents | 122.61 M | |||
Cash Per Share | 0.39 X | |||
Total Debt | 2.57 M | |||
Debt To Equity | 0.02 % | |||
Current Ratio | 3.21 X | |||
Book Value Per Share | 0.34 X | |||
Cash Flow From Operations | (59.33 M) | |||
Earnings Per Share | (0.20) X | |||
Number Of Employees | 11 | |||
Beta | 2.31 | |||
Market Capitalization | 1.44 B | |||
Total Asset | 109.81 M | |||
Net Asset | 109.81 M |
About Telix Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Telix Pharmaceuticals Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Telix Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Telix Pharmaceuticals Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Telix Pink Sheet
When determining whether Telix Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Telix Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Telix Pharmaceuticals Limited Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Telix Pharmaceuticals Limited Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Telix Pharmaceuticals Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.